UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________________________
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
LIGAND PHARMACEUTICALS, INC.
----------------------------
(Name of Issuer)
Common Stock, $0.001 par value per share
-------------------------------------------------
(Title of Class of Securities)
53220K207
---------
(CUSIP Number)
December 31, 2007
-----------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Continued on following pages
Page 1 of 7 Pages
Page 2 of 7 Pages
.................................................................................
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
GLENVIEW CAPITAL MANAGEMENT, LLC
.................................................................................
2. Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
.................................................................................
3. SEC Use Only
.................................................................................
4. Citizenship or Place of Organization
Delaware
.................................................................................
Number of 5. Sole Voting Power None
Shares ...............................................................
Beneficially 6. Shared Voting Power 4,740,431
Owned by ...............................................................
Each 7. Sole Dispositive Power None
Reporting ...............................................................
Person With 8. Shared Dispositive Power 4,740,431
.................................................................................
9. Aggregate Amount Beneficially Owned by Each Reporting Person
4,740,431
.................................................................................
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
[ ]
.................................................................................
11. Percent of Class Represented by Amount in Row (9)
4.97% based on 95,433,477 shares outstanding as of October 31, 2007
.................................................................................
12. Type of Reporting Person:
OO
Page 3 of 7 Pages
.................................................................................
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
LAWRENCE M. ROBBINS
.................................................................................
2. Check the Appropriate Box if a Member of a Group
(a) [ ]
(b) [ ]
.................................................................................
3. SEC Use Only
.................................................................................
4. Citizenship or Place of Organization
United States of America
.................................................................................
Number of 5. Sole Voting Power None
Shares ...............................................................
Beneficially 6. Shared Voting Power 4,740,431
Owned by ...............................................................
Each 7. Sole Dispositive Power None
Reporting ...............................................................
Person With 8. Shared Dispositive Power 4,740,431
.................................................................................
9. Aggregate Amount Beneficially Owned by Each Reporting Person
4,740,431
.................................................................................
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
[ ]
.................................................................................
11. Percent of Class Represented by Amount in Row (9)
4.97% based on 95,433,477 shares outstanding as of October 31, 2007
.................................................................................
12. Type of Reporting Person:
IN
Page 4 of 7 Pages
Item 1(a). Name of Issuer:
Ligand Pharmaceuticals, Inc. (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices:
10275 Science Center Drive, San Diego, CA 92121.
Item 2(a). Name of Person Filing
This Statement is filed on behalf of each of the following
persons (collectively, the "Reporting Persons"):
i) Glenview Capital Management, LLC ("Glenview Capital
Management");
ii) Lawrence M. Robbins ("Mr. Robbins").
This Statement relates to Shares (as defined herein) held for
the accounts of Glenview Capital Partners, L.P., a Delaware limited partnership
("Glenview Capital Partners"), Glenview Capital Master Fund, Ltd., a Cayman
Islands exempted company ("Glenview Capital Master Fund"), Glenview
Institutional Partners, L.P., a Delaware limited partnership ("Glenview
Institutional Partners"), GCM Little Arbor Master Fund, Ltd., a Cayman Islands
exempted company ("GCM Little Arbor Master Fund"), GCM Little Arbor
Institutional Partners, L.P., a Delaware limited partnership ("GCM Little Arbor
Institutional Partners") and GCM Little Arbor Partners, L.P. ("GCM Little Arbor
Partners"), a Delaware limited partnership.
Glenview Capital Management serves as investment manager to each
of Glenview Capital Partners, Glenview Capital Master Fund, Glenview
Institutional Partners, GCM Little Arbor Master Fund, GCM Little Arbor
Institutional Partners and GCM Little Arbor Partners. In such capacity, Glenview
Capital Management may be deemed to have voting and dispositive power over the
Shares held for such accounts. Mr. Robbins is the Chief Executive Officer of
Glenview Capital Management.
Page 5 of 7 Pages
Item 2(b). Address of Principal Business Office or, if None, Residence:
The address of the principal business office of each of Glenview
Capital Management and Mr. Robbins is 767 Fifth Avenue, 44th Floor, New York,
New York 10153.
Item 2(c). Citizenship:
i) Glenview Capital Management is a Delaware limited liability
company;
ii) Mr. Robbins is a citizen of the United States of America.
Item 2(d). Title of Class of Securities:
Common Stock (the "Shares")
Item 2(e). CUSIP Number:
53220K207
Item 3. If This Statement is Filed Pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), Check Whether the Person Filing is a:
This Item 3 is not applicable.
Item 4. Ownership:
Item 4(a) Amount Beneficially Owned:
As of December 31, 2007, each of Glenview Capital Management and
Mr. Robbins may be deemed to be the beneficial owner of 4,740,431 Shares. This
amount consists of: (A) 384,054 Shares held for the account of Glenview Capital
Partners; (B) 1,523,970 Shares held for the account of Glenview Capital Master
Fund; (C) 2,639,551 Shares held for the account of Glenview Institutional
Partners; (D) 111,400 Shares held for the account of the GCM Little Arbor Master
Fund; (E) 77,064 Shares held for the account of GCM Little Arbor Institutional
Partners; and (F) 4,392 Shares held for the account of GCM Little Arbor
Partners.
Item 4(b) Percent of Class:
The number of Shares of which each of Glenview Capital
Management and Mr. Robbins may be deemed to be the beneficial owner constitutes
approximately 4.97% of the total number of Shares outstanding (based upon
information provided by the Issuer in its most recently-filed quarterly report
on Form 10-Q, there were 95,433,477 shares outstanding as of October 31, 2007).
Page 6 of 7 Pages
Item 4(c) Number of Shares of which such person has:
Glenview Capital Management and Mr. Robbins:
--------------------------------------------
(i) Sole power to vote or direct the vote: 0
(ii) Shared power to vote or direct the vote: 4,740,431
(iii) Sole power to dispose or direct the disposition of: 0
(iv) Shared power to dispose or direct the disposition of: 4,740,431
Item 5. Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of
the date hereof the Reporting Person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
This Item 6 is not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
See disclosure in Item 2 hereof.
Item 8. Identification and Classification of Members of the Group:
This Item 8 is not applicable.
Item 9. Notice of Dissolution of Group:
This Item 9 is not applicable.
Item 10. Certification:
By signing below each of the Reporting Persons certifies that,
to the best of their knowledge and belief, the securities referred to above were
not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction
having that purpose or effect.
Page 7 of 7 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 14, 2008 GLENVIEW CAPITAL MANAGEMENT, LLC
By:
/s/ Lawrence M. Robbins
-----------------------
Name: Lawrence M. Robbins
Title: Chief Executive Officer
Date: February 14, 2008 LAWRENCE M. ROBBINS
/s/ Lawrence M. Robbins
-----------------------